Clinical impact of customised positive airway pressure (PAP) therapy interfaces (3DPiPPIn): a single site randomised controlled trial

Journal:
Thorax
Published:
DOI:
10.1136/thorax-2025-224135
Affiliations:
7
Authors:
9
Go to article
Institutions Authors Share
UCL, United Kingdom (UK)
5.000000
 0.56
Royal Free London NHS Foundation Trust, United Kingdom (UK)
2.500000
 0.28
non-affiliated author contributions, United Kingdom (UK)
1.000000
 0.11
Brunel University London, United Kingdom (UK)
0.500000
 0.06
Interested in Cardiovascular Medicine and Haematology?